Tanzania Peaberry (Coffea arabica)
Tanzania Peaberry (Coffea arabica) is a naturally occurring single-seed coffee bean from Tanzania containing concentrated chlorogenic acids (30–55 mg/g in green beans) that inhibit glucose-6-phosphatase and modulate AMPK pathways. Its antioxidant and potential metabolic effects stem primarily from these phenolic compounds, though peaberry-specific human clinical trials remain absent.

Origin & History
Tanzania Peaberry is a cultivar variant of Coffea arabica that grows at high altitudes above 1200 meters on Mt. Kilimanjaro, Tanzania. These unique beans form when a coffee cherry develops a single, rounder, denser seed instead of two flat-sided seeds, occurring in only 5-10% of harvests and manually sorted for their prized concentrated nutrients.
Historical & Cultural Context
No evidence of Tanzania Peaberry in traditional medicine systems was found; it is primarily a modern specialty coffee cultivar valued for flavor rather than medicinal use. While C. arabica originated in Ethiopian forests with historical beverage use, peaberry lacks documented traditional medicinal history.
Health Benefits
• Antioxidant activity: In vitro studies show DPPH radical scavenging (IC50 56.92-66.20 μg/mL CGA equivalent), though human trials are lacking • Contains chlorogenic acid (30-55 mg/g in green beans): A phenolic compound with potential metabolic effects, but no peaberry-specific clinical evidence • Natural caffeine source (0.87-1.78 mg/g): May support alertness, though no peaberry-specific studies exist • Rich in bioactive compounds including caffeic acid, ferulic acid, and trigonelline: Based on general C. arabica analysis, not peaberry-specific research • Potential enhanced nutrient concentration: Anecdotal evidence suggests peaberry density may concentrate nutrients, but lacks scientific validation
How It Works
Chlorogenic acids (CGA) in Tanzania Peaberry inhibit hepatic glucose-6-phosphatase, reducing postprandial glucose release and modulating insulin sensitivity via AMPK activation. CGA also downregulates NF-κB signaling, attenuating pro-inflammatory cytokine production including TNF-α and IL-6. Additionally, caffeine present in the bean antagonizes adenosine A1 and A2A receptors, contributing to CNS stimulation and transient increases in metabolic rate through catecholamine release.
Scientific Research
No human clinical trials, RCTs, or meta-analyses specific to Tanzania Peaberry were identified in the research. General C. arabica studies focus only on chemical composition and in vitro antioxidant activity (DPPH IC50 values of 2.22-2.59 mg/mL for roasted blends), with no PubMed PMIDs available for peaberry-specific biomedical trials.
Clinical Summary
No randomized controlled trials exist specifically examining Tanzania Peaberry as a distinct cultivar; available evidence is extrapolated from broader Coffea arabica and CGA research. In vitro DPPH radical scavenging assays report an IC50 of 56.92–66.20 μg/mL CGA equivalent, indicating moderate antioxidant capacity comparable to other arabica varieties. Human trials on green coffee extract (standardized to 45–50% CGA) have shown modest fasting glucose reductions of 5–10 mg/dL and small body weight decreases (~1–2 kg over 12 weeks) in overweight adults, but these findings cannot be directly attributed to the peaberry form. Overall, evidence quality for peaberry-specific health outcomes is low, relying on in vitro data and cultivar-class extrapolation.
Nutritional Profile
Tanzania Peaberry (Coffea arabica) nutritional composition per 100g green bean basis: Macronutrients — Carbohydrates 60-65g (primarily sucrose 6-9g, polysaccharides 50-55g), Protein 10-13g (including free amino acids such as glutamic acid, aspartic acid, and asparagine contributing to roast flavor), Total Fat 12-16g (predominantly linoleic acid 40-45% of lipid fraction, palmitic acid 25-30%, oleic acid 10-15%), Dietary Fiber 33-40g (mostly mannans and arabinogalactans in cell wall matrix). Moisture in green beans approximately 10-12%. Micronutrients — Potassium 1,600-2,000mg/100g (highest mineral by concentration), Magnesium 150-200mg/100g, Calcium 85-130mg/100g, Phosphorus 140-180mg/100g, Iron 3-5mg/100g, Zinc 0.5-1.0mg/100g, Manganese 1.0-2.0mg/100g; B-vitamins present including niacin (trigonelline degrades to niacin upon roasting, yielding 10-40mg/100g roasted), riboflavin trace amounts (~0.2mg/100g). Bioactive Compounds — Chlorogenic acids (CGAs) 30-55mg/g green bean weight, predominantly 5-caffeoylquinic acid (5-CQA); caffeine 0.87-1.78mg/g (lower range typical of high-altitude Tanzanian arabica); trigonelline 6-10mg/g green bean; melanoidins form during roasting (10-25% of roasted bean weight) contributing antioxidant capacity. Bioavailability Notes — CGA bioavailability is moderate (~33% absorbed in small intestine), with remainder metabolized by colonic microbiota to hydroxycinnamic acids; caffeine is near-completely absorbed (99%); mineral bioavailability is reduced by binding to polyphenols and fiber; roasting reduces CGA content by 50-95% depending on roast degree, while simultaneously forming melanoidins with independent antioxidant properties. Peaberry-specific compositional data is limited; values reflect Tanzanian Coffea arabica benchmarks, with peaberry morphology (single ovule per cherry) theorized to concentrate flavor compounds but lacking confirmed differential nutritional quantification versus flat-bean counterparts.
Preparation & Dosage
No clinically studied dosage ranges exist for Tanzania Peaberry in biomedical contexts. General C. arabica analyses report chlorogenic acid at 30-55 mg/g and caffeine at 0.87-1.78 mg/g in unroasted forms, but no standardization or clinical dosing has been established. Consult a healthcare provider before starting any new supplement.
Synergy & Pairings
Green tea extract, L-theanine, rhodiola, ashwagandha, cordyceps
Safety & Interactions
Tanzania Peaberry coffee is generally safe for healthy adults at typical dietary intakes, but high caffeine content (80–120 mg per standard serving) may cause insomnia, tachycardia, and anxiety, particularly in caffeine-sensitive individuals. CGA can inhibit non-heme iron absorption by up to 25–35% when consumed with iron-rich meals, posing a risk for individuals prone to iron-deficiency anemia. Caffeine interacts with adenosine-based medications, MAO inhibitors, and anticoagulants such as warfarin by competing for CYP1A2 hepatic metabolism, potentially altering drug plasma levels. Pregnant women are advised to limit total caffeine intake to under 200 mg/day per WHO and ACOG guidelines, making high-dose green coffee extracts inadvisable during pregnancy.